Article info

Original research
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

Authors

Citation

Seyfrid M, Maich WT, Shaikh MV, et al
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.